Glycated albumin levels are associated with adverse stroke outcomes in patients with acute ischemic stroke in China.

This study demonstrated that elevated GA levels in serum were associated with stroke adverse outcomes, including stroke recurrence, poor functional outcomes, and combined vascular events, in patients with ischemic stroke or TIA.